fda warning letter bpc-157 2024 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval Bpc-157 Lyophilized Powder For Size:2mg tesamorelin vial
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29